Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Influenza |
Free Subscription
1 Arch Virol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Influenza is free of charge.
Identification and characterization of a marine bacterium extract from Mameliella
sp. M20D2D8 with antiviral effects against influenza A and B viruses.
Arch Virol. 2024;169:41.
PubMed
Abstract available
Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus
VP4, and HIV Vpu.
Biochemistry. 2024;63:241-250.
PubMed
Abstract available
Assessing pattern of the Pediatric Multisystem Inflammatory Syndrome (PMIS) in
children during the COVID-19 pandemic: experience from the emergency department
of tertiary care center of a low-middle-income country.
BMC Pediatr. 2024;24:98.
PubMed
Abstract available
Impact of COVID?19 pandemic restrictions and subsequent relaxation on the
prevalence of respiratory virus hospitalizations in children.
BMC Pediatr. 2024;24:91.
PubMed
Abstract available
Pulmonary function in children post -SARS-CoV-2 infection: a systematic review
and meta-analysis.
BMC Pediatr. 2024;24:87.
PubMed
Abstract available
US public health after covid-19: learning from the failures of the hollow state
and racial capitalism.
BMJ. 2024;384:e076969.
PubMed
After covid-19: the case for optimism for US leadership in global health.
BMJ. 2024;384:q138.
PubMed
Covid inquiry: Tears and tensions as Sturgeon takes the stand.
BMJ. 2024;384:q289.
PubMed
Cognitive dysfunction after covid-19.
BMJ. 2024;384:e075387.
PubMed
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip
variants.
Cell. 2024;187:585-595.
PubMed
Abstract available
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high
efficiency.
Cell. 2024;187:596-608.
PubMed
Abstract available
Case-control study of behavioural and societal risk factors for sporadic
SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).
Epidemiol Infect. 2024;152:e16.
PubMed
Abstract available
Latent gammaherpesvirus infection enhances type I IFN response and reduces virus
spread in an influenza A virus co-infection model.
J Gen Virol. 2024;105.
PubMed
Abstract available
Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against
Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and
Syrian Golden Hamster Models.
J Immunol. 2024;212:576-585.
PubMed
Abstract available
Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting
Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
J Immunol. 2024;212:523-528.
PubMed
Abstract available
Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
J Immunol. 2024;212:505-512.
PubMed
Abstract available
SARS-CoV-2 Delta and Omicron community transmission networks as added value to
contact tracing.
J Infect. 2024 Jan 17:S0163-4453(24)00023-9. doi: 10.1016/j.jinf.2024.
PubMed
Abstract available
Stillbirths due to placental COVID infection associated with chronic histiocytic
intervillositis do not recur in subsequent pregnancies.
J Infect. 2024 Jan 11:S0163-4453(24)00020-3. doi: 10.1016/j.jinf.2024.
PubMed
Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar
antiviral potency.
J Infect. 2024 Jan 6:S0163-4453(23)00600-X. doi: 10.1016/j.jinf.2023.
PubMed
Characteristics of innate, humoral and cellular immunity in children with
non-severe SARS-CoV-2 infection.
J Infect. 2023 Dec 13:S0163-4453(23)00589-3. doi: 10.1016/j.jinf.2023.
PubMed
Abstract available
Persistence of post-COVID symptoms in the general population two years after
SARS-CoV-2 infection: A systematic review and meta-analysis.
J Infect. 2023 Dec 13:S0163-4453(23)00590-X. doi: 10.1016/j.jinf.2023.
PubMed
Abstract available
Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC)
after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker
cohort.
J Infect. 2023 Dec 7:S0163-4453(23)00588-1. doi: 10.1016/j.jinf.2023.
PubMed
Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild
symptomatic COVID-19 patients.
J Infect. 2023 Nov 20:S0163-4453(23)00562-5. doi: 10.1016/j.jinf.2023.
PubMed
How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity
dynamics: an 18-month longitudinal study.
J Infect. 2023 Nov 17:S0163-4453(23)00558-3. doi: 10.1016/j.jinf.2023.
PubMed
Risk of cardiovascular events after influenza: A population-based Self Controlled
Case Series study, Spain 2011-2018.
J Infect Dis. 2024 Feb 8:jiae070. doi: 10.1093.
PubMed
Abstract available
Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a
high-fidelity cellular model for investigating HIV-1, dengue, and influenza
viruses.
J Virol. 2024 Feb 7:e0156323. doi: 10.1128/jvi.01563.
PubMed
Abstract available
Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon
influenza virus infection by subtraction of the background antibody repertoire.
J Virol. 2024 Feb 7:e0199523. doi: 10.1128/jvi.01995.
PubMed
Abstract available
Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
JAMA. 2024;331:396-407.
PubMed
Abstract available
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2
Infection in Children and Adolescents Aged 5 to 17 Years.
JAMA. 2024;331:408-416.
PubMed
Abstract available
As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2
"Variant of Interest".
JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
PubMed
From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent
Respiratory Disease Surges.
JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
PubMed
The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic:
planning, outcomes, and lessons learnt.
Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
PubMed
Abstract available
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine
Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to
Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing
Community Access to Testing Pro
MMWR Morb Mortal Wkly Rep. 2024;73:77-83.
PubMed
Abstract available
Enhancing our understanding of short-term rental activity: A daily scrape-based
approach for Airbnb listings.
PLoS One. 2024;19:e0298131.
PubMed
Abstract available
Does the resumption of international tourism heighten COVID-19 transmission?
PLoS One. 2024;19:e0295249.
PubMed
Abstract available
Factors associated with anxiety during the first two years of the COVID-19
pandemic in the United States: An analysis of the COVID-19 Citizen Science study.
PLoS One. 2024;19:e0297922.
PubMed
Abstract available
A retrospective analysis of malaria deaths in the pre- and intra- COVID 19
pandemic era, Ghana, 2016-2021.
PLoS One. 2024;19:e0286212.
PubMed
Abstract available
Covid-19 demography in France and South Africa: A comparative study of morbidity
and mortality in 2020-2022.
PLoS One. 2024;19:e0294870.
PubMed
Abstract available
COVID-19 related morbidity and mortality in people experiencing homelessness in
the Netherlands.
PLoS One. 2024;19:e0296754.
PubMed
Abstract available
Effects of pulmonary rehabilitation on ventilation dynamics measured during
exertion in patients with post-acute COVID-19 syndrome: A cross-sectional
observational study.
PLoS One. 2024;19:e0296707.
PubMed
Abstract available
Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions
and behavior among international and domestic college students in the United
States.
PLoS One. 2024;19:e0293130.
PubMed
Abstract available
Starting an undergraduate degree amid the COVID-19 pandemic: A mixed-method
egocentric network study on student loneliness.
PLoS One. 2024;19:e0297953.
PubMed
Abstract available
Analyzing metaphor patterns in COVID-19 news pictures: A critical study in China.
PLoS One. 2024;19:e0297336.
PubMed
Abstract available
A qualitative study examining the health system's response to COVID-19 in Sierra
Leone.
PLoS One. 2024;19:e0294391.
PubMed
Abstract available
Fever clinic construction and management targeted to prevention and control of
healthcare-associated respiratory viral infections in Jiangsu, China: A
cross-sectional observational study.
PLoS One. 2024;19:e0297133.
PubMed
Abstract available
Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with
meta-analysis and trial sequential analysis.
PLoS One. 2024;19:e0297628.
PubMed
Abstract available
Analysis of characteristics of and risk factors for otological symptoms after
COVID-19 infection.
PLoS One. 2024;19:e0297100.
PubMed
Abstract available
Physical activity and unexpected weight change in Ontario children and youth
during the COVID-19 pandemic: A cross-sectional analysis of the Ontario Parent
Survey 2.
PLoS One. 2024;19:e0292934.
PubMed
Abstract available
Knowledge, attitude and perception towards COVID-19 among representative educated
sub-Saharan Africans: A cross-sectional study during the exponential phase of the
pandemic.
PLoS One. 2024;19:e0281342.
PubMed
Abstract available
Intolerance of uncertainty and mental health in China "Post-pandemic" age: The
mediating role of difficulties in emotion regulation.
PLoS One. 2024;19:e0298044.
PubMed
Abstract available
Prevalence and factors associated with mental illness symptoms among school
students post lockdown of the COVID-19 pandemic in the United Arab Emirates: A
cross-sectional national study.
PLoS One. 2024;19:e0296479.
PubMed
Abstract available
Understanding spatiotemporal patterns of COVID-19 incidence in Portugal: A
functional data analysis from August 2020 to March 2022.
PLoS One. 2024;19:e0297772.
PubMed
Abstract available
Precision treatment of viral pneumonia through macrophage-targeted lipid
nanoparticle delivery.
Proc Natl Acad Sci U S A. 2024;121:e2314747121.
PubMed
Abstract available
Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that
reassemble into proinflammatory supramolecular complexes.
Proc Natl Acad Sci U S A. 2024;121:e2300644120.
PubMed
Abstract available
Excess natural-cause mortality in US counties and its association with reported
COVID-19 deaths.
Proc Natl Acad Sci U S A. 2024;121:e2313661121.
PubMed
Abstract available
Parental concerns and vaccine hesitancy against COVID-19 vaccination for children
in Greece: A cross-sectional survey.
Vaccine. 2024 Jan 6:S0264-410X(24)00003-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Exploring preventive care practices among unvaccinated individuals in the United
States during the COVID-19 pandemic.
Vaccine. 2024;42:441-447.
PubMed
Abstract available
Racial and ethnic differences in COVID-19 vaccine readiness among adults in the
United States, January 2021-April 2023.
Vaccine. 2024 Jan 4:S0264-410X(23)01537-2. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with
thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A
cross-sectional study in six EU member states.
Vaccine. 2024 Jan 4:S0264-410X(23)01511-6. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Massachusetts companion program bolsters COVID-19 vaccine rates among seniors.
Vaccine. 2024 Jan 3:S0264-410X(23)01494-9. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
"I shall not poison my child with your human experiment": Investigating
predictors of parents' hesitancy about vaccinating younger children (<12) in
Canada.
Vaccine. 2024 Jan 2:S0264-410X(23)01519-0. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Social determinants of health and vaccine uptake in pregnancy: Disparities in a
diverse, predominately foreign-born population.
Vaccine. 2024 Jan 2:S0264-410X(23)01515-3. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Do vaccines increase or decrease susceptibility to diseases other than those they
protect against?
Vaccine. 2023 Dec 28:S0264-410X(23)01506-2. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in
Victoria, Australia: A clinical surveillance study.
Vaccine. 2023 Dec 27:S0264-410X(23)01516-5. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general
in the USA.
Vaccine. 2023 Dec 23:S0264-410X(23)01488-3. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Vaccine-associated respiratory pathology correlates with viral clearance and
protective immunity after immunization with self-amplifying RNA expressing the
spike (S) protein of SARS-CoV-2 in mouse models.
Vaccine. 2023 Dec 22:S0264-410X(23)01498-6. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in
Quebec, Canada, during the Delta and early Omicron periods.
Vaccine. 2023 Dec 22:S0264-410X(23)01489-5. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373
(TAK-019) in healthy Japanese adults who had previously received a primary series
of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial.
Vaccine. 2023 Dec 20:S0264-410X(23)01482-2. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Humoral immune response in people living with HIV after administration of
SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence:
A cross-sectional study.
Vaccine. 2023 Dec 19:S0264-410X(23)01481-0. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy,
invasive mechanical ventilation, and death in Japan: A multicenter case-control
study (MOTIVATE study).
Vaccine. 2023 Dec 18:S0264-410X(23)01480-9. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Isolation and characterization of genotype 4 Eurasian avian-like H1N1 influenza
virus in pigs suffering from pneumonia.
Virology. 2024;592:110009.
PubMed
Abstract available
Systems Genetics of Influenza A Virus-infected Mice Identifies TRIM21 as a
Critical Regulator of Pulmonary Innate Immune Response.
Virus Res. 2024 Feb 6:199335. doi: 10.1016/j.virusres.2024.199335.
PubMed
Abstract available
Thank you for your interest in scientific medicine.